<p>TYK MEDICINES-B (02410.HK) announced that it has received a drug manufacturing license from the Zhejiang Provincial Drug Administration, allowing the production of Alectinib Mesylate Tablets. This is expected to have a long-term positive impact on the company's capacity expansion and market development, laying the foundation for future commercial production</p>

02410

516500

510660

159837

512010

516930

513700

512290

159849

588130

<p>TYK MEDICINES-B announced that it has received a drug manufacturing license issued by the Zhejiang Provincial Drug Administration, allowing the production of Alectinib Mesylate Tablets. This is expected to have a long-term positive impact on the company's capacity expansion and market development, laying the foundation for subsequent commercial production</p>

AASTOCKS

TYK MEDICINES-B

ChinaAMC CSI Biotechnology Theme ETF

ChinaAMC SSE Health Care ETF Initiating Fund

E Fund CSI Biotechnology Theme ETF

E Fund CSI 300 Health Care ETF

Minsheng Royal CSI Biotechnology Theme ETF

Penghua CSI HK Connect Health Care Composite ETF

Guotai CSI Bio-medicine ETF

China Merchants CSI Biotechnology Theme ETF

ChinaAMC SSE STAR Biology and Medicine ETF

TYK MEDICINES has obtained a drug production license from the Zhejiang Provincial Drug Administration